These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33994282)

  • 1. Fondaparinux During Intra-Aortic Balloon Pump Counterpulsation in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention.
    De Luca L; Uguccioni M; Putini RL; Natale E; Terranova A; Pugliese M; Biffani E; De Lio L; Piazza V; Musumeci F
    Heart Lung Circ; 2021 Oct; 30(10):1545-1551. PubMed ID: 33994282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of fondaparinux vs unfractionated heparin following percutaneous coronary intervention in survivors of out-of-hospital cardiac arrest due to acute myocardial infarction.
    De Luca L; Uguccioni M; Natale E; Pugliese M; Terranova A; Biffani E; De Lio L; Piazza V; Putini RL; Musumeci F
    Eur J Clin Pharmacol; 2021 Oct; 77(10):1563-1567. PubMed ID: 33963425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of mortality in patients with cardiogenic shock treated with primary percutaneous coronary intervention and intra-aortic balloon counterpulsation.
    Schwarz B; Abdel-Wahab M; Robinson DR; Richardt G
    Med Klin Intensivmed Notfmed; 2016 Nov; 111(8):715-722. PubMed ID: 26596273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock.
    Dhruva SS; Ross JS; Mortazavi BJ; Hurley NC; Krumholz HM; Curtis JP; Berkowitz A; Masoudi FA; Messenger JC; Parzynski CS; Ngufor C; Girotra S; Amin AP; Shah ND; Desai NR
    JAMA; 2020 Feb; 323(8):734-745. PubMed ID: 32040163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the Use of Unfractionated Heparin with Intra-Aortic Balloon Counterpulsation.
    Nuti O; Merchan C; Papadopoulos J; Horowitz J; Rao SV; Ahuja T
    Heart Lung Circ; 2024 Jul; 33(7):975-982. PubMed ID: 38575436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of intra-aortic balloon pump support initiated before versus after primary percutaneous coronary intervention in patients with cardiogenic shock from acute myocardial infarction.
    Cheng JM; van Leeuwen MA; de Boer SP; Wai MC; den Uil CA; Jewbali LS; van Geuns RJ; Kardys I; van Domburg RT; Boersma E; Zijlstra F; Akkerhuis KM
    Int J Cardiol; 2013 Oct; 168(4):3758-63. PubMed ID: 23830073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of hospital mortality with intra-aortic balloon counterpulsation insertion before versus after primary percutaneous coronary intervention for cardiogenic shock complicating acute myocardial infarction.
    Abdel-Wahab M; Saad M; Kynast J; Geist V; Sherif MA; Richardt G; Toelg R
    Am J Cardiol; 2010 Apr; 105(7):967-71. PubMed ID: 20346314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Short and intermediate term clinical outcome in patients with cardiogenic shock treated with aortic counterpulsation].
    Fornaro G; Prando MD; Parodi F; Cordero G; Sansa M; Bongo AS; Campi A; Aralda D; Dellavesa P; Aina F; Lazzero M; Cernigliaro C
    G Ital Cardiol; 1996 Dec; 26(12):1385-99. PubMed ID: 9162668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effectiveness of intra-aortic balloon pump for myocardial infarction in patients with or without cardiogenic shock: a meta-analysis and systematic review.
    Zheng XY; Wang Y; Chen Y; Wang X; Chen L; Li J; Zheng ZG
    BMC Cardiovasc Disord; 2016 Jul; 16(1):148. PubMed ID: 27391391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing of initiation of intra-aortic balloon pump in patients with acute myocardial infarction complicated by cardiogenic shock: A meta-analysis.
    Cui K; Lyu S; Liu H; Song X; Yuan F; Xu F; Zhang M; Zhang M; Wang W; Zhang D; Tian J; Yan Y; Zhou K; Chen L
    Clin Cardiol; 2019 Nov; 42(11):1126-1134. PubMed ID: 31509267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome.
    Prondzinsky R; Lemm H; Swyter M; Wegener N; Unverzagt S; Carter JM; Russ M; Schlitt A; Buerke U; Christoph A; Schmidt H; Winkler M; Thiery J; Werdan K; Buerke M
    Crit Care Med; 2010 Jan; 38(1):152-60. PubMed ID: 19770739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the timing of treatment with intra-aortic balloon counterpulsation in cardiogenic shock due to ST-elevation myocardial infarction affect survival?
    Bergh N; Angerås O; Albertsson P; Dworeck C; Matejka G; Haraldsson I; Ioanes D; Libungan B; Odenstedt J; Petursson P; Ridderstråle W; Råmunddal T; Omerovic E
    Acute Card Care; 2014 Jun; 16(2):57-62. PubMed ID: 24670205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Outcomes and Cost Associated With an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump in Patients Presenting With Acute Myocardial Infarction Complicated by Cardiogenic Shock.
    Miller PE; Bromfield SG; Ma Q; Crawford G; Whitney J; DeVries A; Desai NR
    JAMA Intern Med; 2022 Sep; 182(9):926-933. PubMed ID: 35849410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary trends in cardiogenic shock: Incidence, intra-aortic balloon pump utilisation and outcomes from the London Heart Attack Group.
    Rathod KS; Koganti S; Iqbal MB; Jain AK; Kalra SS; Astroulakis Z; Lim P; Rakhit R; Dalby MC; Lockie T; Malik IS; Knight CJ; Whitbread M; Mathur A; Redwood S; MacCarthy PA; Sirker A; O'Mahony C; Wragg A; Jones DA
    Eur Heart J Acute Cardiovasc Care; 2018 Feb; 7(1):16-27. PubMed ID: 29111770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Intra-aortic Balloon Pump before versus after Primary Percutaneous Coronary Intervention in Patients with Cardiogenic Shock from ST-elevation Myocardial Infarction.
    Yuan L; Nie SP
    Chin Med J (Engl); 2016 Jun; 129(12):1400-5. PubMed ID: 27270533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Safety between Different Kinds of Heparins in Patients Receiving Intra-Aortic Balloon Counterpulsation.
    Guan X; Chen M; Li Y; Zhang J; Xu L; Sun H; Zhang D; Wang L; Yang X
    Thorac Cardiovasc Surg; 2021 Sep; 69(6):511-517. PubMed ID: 32998166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of intra-aortic balloon pump counterpulsation in the treatment of acute myocardial infarction complicated by cardiogenic shock: Evidence from the Portuguese nationwide registry.
    Timóteo AT; Nogueira MA; Rosa SA; Belo A; Ferreira RC;
    Eur Heart J Acute Cardiovasc Care; 2016 Nov; 5(7):23-31. PubMed ID: 26373810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: the benchmark registry.
    Stone GW; Ohman EM; Miller MF; Joseph DL; Christenson JT; Cohen M; Urban PM; Reddy RC; Freedman RJ; Staman KL; Ferguson JJ
    J Am Coll Cardiol; 2003 Jun; 41(11):1940-5. PubMed ID: 12798561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular outcomes using intra-aortic balloon pump in high-risk acute myocardial infarction with or without cardiogenic shock: a meta-analysis.
    Bahekar A; Singh M; Singh S; Bhuriya R; Ahmad K; Khosla S; Arora R
    J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):44-56. PubMed ID: 21335478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial.
    Perera D; Stables R; Thomas M; Booth J; Pitt M; Blackman D; de Belder A; Redwood S;
    JAMA; 2010 Aug; 304(8):867-74. PubMed ID: 20736470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.